INTRODUCTION
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Purpose: Nearly 100% of infantile Tay-Sachs disease is
Tay-Sachs disease is a lysosomal storage disease 
plantation genetic diagnosis and to investigate the occur-
In the Ashkenazi population, nearly 100% of infanrence of allele dropout.
tile Tay-Sachs disease is produced by two mutations.
Methods: New nested primers were designed to optimize
The first major mutation accounting for approximately In addition to the tubes containing DNA from 300 mM potassium chloride, 200 mM hydrochloric acid) was then added and brought to 52 l with sterile samples being tested, reaction tubes containing only master mix reagents plus water (without added DNA) ultra pure water (5).
were run simultaneously as negative controls against possible contamination from extraneous DNA. Because these controls contained no added DNA, no Polymerase Chain Reaction (PCR) amplification signal should be seen. Any amplification observed in these tubes would indicate a contaminating Primer Design. A novel single reaction nested primer system utilizing 3 outer primers was designed DNA source of unknown origin. Evidence of contamination will invalidate the experimental set. using Primer Designer3 (Scientific & Educational Software) and sequences obtained from Genebank (S62047911 and S62047912). The extra primer (#22) Analysis of PCR Product was used to selectively enhance the product for and detection of the exon 11 mutation sequence (see Sizes of the expected second run amplified products are 206bp (exon 11) and 135bp (intron 12). Ref. 14) .
The outer-primers were: #16-GCCAGACACAAT-CATACAGG; #18-TCCTGCTCTCAGGCCCAACCHeteroduplex Formation CTC (6); and #22-CAACAACAGTCTGGTGATGG (7).
The nested primers for the 4 base pair insertion In order to specifically identify the amplification products in the presence of the 4bp insertion exon mutation in exon 11 were: #16 and #43-CTTTGG-TTAGCAAGGAGAG.
11 mutation, reannealing of the PCR products was performed to produce an artifact-heteroduplex formaThe primers for the intron 12 (G Ͼ C) splice-site mutation were: #20-CCCCTGAGCAGAAGGCTCTtion. PCR product from both a known normal DNA (6.5 l) and unknown DNA sample (6.5 l) was placed GGTG and #18 (Figure 1) .
First Run PCR. The initial 90 1 reaction volume in a reaction tube. The mixture was denatured at 95ЊC for 5 min, and then allowed to reanneal at 65ЊC for containing DNA (single cell) and consisting of PCR buffer [(2.5 mM MgCl 2 , 10 mM Tris-HCl, pH 8.3, 33 5 min. Electrophoresis of 10 l of the reaction was performed using 10% polyacrylamide gels which were mM KCl, 0.01% wt/vol gelatin), 200 M dNTP (Perkin Elmer), 0.1 M outer primers, and 3 U "AmpliTaq then stained with SYBR Green I (8). The PCR product of the sample cell with an unknown DNA status was Gold" polymerase (Perkin Elmer)] was placed in a DNA thermal cycler (Perkin Elmer PCR system 9600).
run on two lanes of the gel, alone and with the known homozygous normal DNA PCR product. The followAfter an initial denaturation of 96ЊC for 12 min, two programs were used in succession for the first run ing results were observed (Fig. 2) . If the two lanes both formed a single band, then the sample was diagnosed as PCR: (1) five cycles were carried out using 97ЊC denaturation for 30 s, 68ЊC annealing for 45 s, and normal. If the unknown sample (run by itself) forms a heteroduplex-banding pattern (extra two higher bands), 72ЊC extension for 45 s; (2) twenty cycles were carried out using 95ЊC denaturation for 20 s, 68ЊC annealing then the unknown sample contains both a normal and abnormal allele and is therefore a heterozygote-carrier. for 30 s, and 72ЊC extension for 45 s. Final product extension was carried out at 72ЊC for 12 min.
If the untreated sample lane forms a single band and the mixed lane forms the heteroduplex banding pattern, Tay-Sachs 4bp insertion mutation in exon 11. In addition, 117 known heterozygous fibroblasts were tested then the diagnosis of the unknown sample is homozygous affected.
for the same mutation. In other experiments, 232 lymphoblasts (heterozygotes) were tested for the intron 12 (G Ͼ C) splice-site mutation. The total efficiency Enzymatic Digestion of amplification for the combined tests was 85.3% (390/457). The allele dropout rate for the exon 11 In order to determine the status of the exon 12 mutation, 5 l of PCR product was placed in 20 l 1X carrier and the intron 12 splice-site heterozygote, was 4.8% and 5.8%, respectively. Sequencing data (not React 3 buffer containing 5 unit DdeI (BRL). Digestion occurred at 37ЊC for one hr. The digest was then subshown) of second run products verified the correct sequence amplification in the primer-guided reactions. mitted to electrophoresis on a 10% polyacrylamide gel that was then stained by SYBR Green as above. For a normal allele, the 135bp PCR product is cut into three fragments of 120, 11, and 4bp. In contrast, the DISCUSSION mutated allele yields four fragments of 85, 35, 11, and 4bp. Heterozygotes give fragments of 120, 85, 35, 11, Two mutations are commonly linked to Tay-Sachs disease in the Jewish population. A 4bp insertion in and 4bps (Fig. 3) (4) . Fragments 11bp and 4bp are not observed under the conditions employed for electroexon 11 and a splice-site mutation at 5Ј end of intron 12 (G Ͼ C) account for almost all Tay-Sachs disease phoresis. Control samples containing plasmid pBR-322 DNA (25ng) were run to confirm enzyme digesin Ashkenazi Jews. We have developed a new single reaction primer system that can be used to amplify tion activity.
these two Tay-Sachs mutations simultaneously. This system constitutes a more robust test for these mutations delivering stronger signal generation and lower RESULTS ADO rates than those previously described for single cell preimplantation genetic diagnosis. Making use of the described primer sets, 108 fibroblasts (comprising 50 normal cells and 58 affected
Although others have described primer systems used to amplify both mutation sites (6,7), those primers led homozygous cells) were tested as single cells for the either to unconfirmed products or weak signals in our carrier, when the cell is diagnosed as normal, due to allelic dropout. Transferring a carrier embryo instead laboratory. We have employed a novel outer primer technique, utilizing three primers, to initiate amplificaof a normal embryo in approximately 5% of embryos is a clinically acceptable situation since the offspring tion of initial products. This system helped generate specific first round amplification products while newly will not be affected by the disease. However, if the embryo is a compound heterozygote, and diagnosed arranged inner primers enhanced signal strength. The third first round primer was used to selectively enhance as normal, there will be an additional 0.25% probability of the embryo actually being affected with the disease the production of exon 11 sequences (14) .
Along with generating specific tests for these mutadue to a double dropout occurrence. This can occur due to the separate amplification of each mutation tions, it was important to determine the allele dropout rate. Other publications have also discussed the imporduring the second round of PCR amplification. Likewise, if the embryo is diagnosed as a heterozygote, tance of allele dropouts in heterozygote and compound heterozygote situations and how they may affect the there will be a 5% chance that it will actually be affected with the disease. Thus, it would never be procedure clinically (9,10,11,12,13).
We screened 108 fibroblasts (including 50 normal clinically acceptable to transfer a carrier in the case of compound heterozygotes (Table I) . and 58 homozygous cells) and 117 heterozygous fibroblasts for a 4bp insertion mutation in exon 11. We also In order to reduce the risk of transferring a compound heterozygote embryo, which may be affected tested 232 lymphoblast cells (heterozygotes) for intron 12 splice-site mutations. The combined efficiency of by Tay-Sachs after birth, two embryonic cells should be tested for each embryo. Only when both cells concur amplification was 85.3% in our setting and compares to 89.5% for those amplifying both Tay-Sachs mutations a normal status can there be assurance (99.875%) that the disease will not be transferred. If cells are diagsimultaneously (6). We also determined the allele dropout rates as 4.8% and 5.8%, respectively. Single cell nosed as carriers in this situation (two cells), then there is only a 0.25% chance that the embryo will be affected. amplification efficiencies and dropout rates can vary greatly depending on cell type, numbers reported, as However, since one half of those embryos will not concur as to the allele that dropped out and therefore well as, solubilizing conditions, and various PCR parameters.
not be transferred, this leaves only half the number of carriers, or 0.125% chance, that a diagnosed carrier There is virtually no danger of transferring an affected embryo due to allelic dropout when a cell is will actually be returned affected with the disease (Table I) . homozygous (including either affected or normal cells), since the remaining allele will correctly identify It is important to determine allelic dropout rates with each new primer system in order to accurately the cell (barring contamination of the sample by extraneous DNA). In the case of heterozygote or compound assess the probabilities of transmitting disease with the embryos. Allelic dropout rates are also the basis heterozygote cells however, there is a 4.8% ϳ 5.8% chance that the embryo will actually be a heterozygotic of informing the patient of the chances of having an 
